Literature DB >> 8043932

Biochemical aspects of the blood group Rh (rhesus) antigens.

D J Anstee1, M J Tanner.   

Abstract

Despite their importance in clinical haematology, the details of the structures and possible functions of the proteins associated with Rh antigen expression have only recently begun to emerge. The antigens are carried by a multimeric complex between a M(r) 30,000 polypeptide which is not glycosylated (the Rh30 polypeptide), and a heavily glycosylated glycoprotein (the Rh50 glycoprotein). The N-terminal amino acid sequences of the two types of proteins were determined and used to isolated cDNA clones. The Rh30 and Rh50 proteins are both very hydrophobic membrane proteins, each containing up to 12 membrane spans. The two proteins are homologous in sequence and clearly belong to the same family. They are erythroid-specific and not related to any other known family of proteins. The Rh30 polypeptides are the genetic determinants of Rh blood group antigen activity. One polypeptide (Rh30A) is probably associated with CcEe antigen activity, while another (Rh30B) is responsible for the D antigen. The proteins have structures typical of transporters but their functions are still unclear. A number of other red cell membrane proteins (LW, CD47, glycophorin B and Fy) show alterations in red cells lacking Rh antigens (Rhnull). These proteins may have a role in the biosynthesis or function of the Rh30 and Rh50 proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8043932     DOI: 10.1016/s0950-3536(05)80152-0

Source DB:  PubMed          Journal:  Baillieres Clin Haematol        ISSN: 0950-3536


  14 in total

1.  Rhesus expression in a green alga is regulated by CO(2).

Authors:  Eric Soupene; Natalie King; Eithne Feild; Phillip Liu; Krishna K Niyogi; Cheng-Han Huang; Sydney Kustu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  Structural analysis of the RH-like blood group gene products in nonhuman primates.

Authors:  I Salvignol; P Calvas; W W Socha; Y Colin; C Le Van Kim; P Bailly; J Ruffié; J P Cartron; A Blancher
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Genetic recombination at the human RH locus: a family study of the red-cell Evans phenotype reveals a transfer of exons 2-6 from the RHD to the RHCE gene.

Authors:  C H Huang; Y Chen; M Reid; S Ghosh
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

4.  Characterization of the recombination hot spot involved in the genomic rearrangement leading to the hybrid D-CE-D gene in the D(VI) phenotype.

Authors:  G Matassi; B Chérif-Zahar; I Mouro; J P Cartron
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

5.  Molecular definition of red cell Rh haplotypes by tightly linked SphI RFLPs.

Authors:  C H Huang; M E Reid; Y Chen; G Coghlan; Y Okubo
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

6.  The two-gene model of the RH blood-group locus.

Authors:  J P Cartron; C Le Van Kim; B Cherif-Zahar; I Mouro; C Rouillac; Y Colin
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

7.  A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression.

Authors:  Patrick T McGann; Jenny M Despotovic; Thad A Howard; Russell E Ware
Journal:  Am J Hematol       Date:  2011-11-25       Impact factor: 10.047

Review 8.  Blood type biochemistry and human disease.

Authors:  D Rose Ewald; Susan C J Sumner
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-09-07

9.  Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies.

Authors:  Dylana Díaz-Solano; Jaheli Fuenmayor; Ramon F Montaño
Journal:  Blood Transfus       Date:  2017-05-30       Impact factor: 3.443

Review 10.  The Rh protein family: gene evolution, membrane biology, and disease association.

Authors:  Cheng-Han Huang; Mao Ye
Journal:  Cell Mol Life Sci       Date:  2009-12-02       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.